MedImpact Holdings, Inc. today announced the launch of an unbranded biosimilar to Humira® (adalimumab) priced at 95% below ...

BCBS Michigan saved $67 million and $80 million in 2024 and 2025, respectively, through biosimilar use, the insurer reported Feb. 17. The company began moving members from Humira and Stelara to ...

The total net revenues of AbbVie's Rinvoq and Skyrizi were about $25.87 billion in 2025, up 46.2% from 2024. Read why ABBV ...

AbbVie Inc. Q4 2025 shows SKYRIZI/RINVOQ strength but diversification risks and M&A reliance. Click here to read this earnings analysis of ABBV stock.

Tuesday, February 17, 2026 The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including AbbVie Inc ...

Cigna’s fourth quarter results were well received by the market, reflecting the company’s ability to navigate industry disruptions and deliver on key growth priorities. Management credited the quarter ...

Delhi’s degraded mining pits now shelter orchids, jackals, and over 230 bird species. These biodiversity parks show how ...

The Trump administration’s new website to help consumers find cheaper drugs is a worthy objective, but it comes with ...

CVS Health this morning reported earnings in line with expectations. In 2025, the giant healthcare company saw record earnings of $402.1 billion, up 7.8% compared with the year before. The lull-year ...

AbbVie Inc. (NYSE:ABBV) Q4 2025 Earnings Call Transcript February 4, 2026 AbbVie Inc. beats earnings expectations. Reported ...

Supreme Group, a marketing and communications platform for healthcare and life sciences, today announced the acquisition of Broth, a science-first creative agency that brings insight and precision to ...

The Association of Ontario Midwives is calling on the Ministry of Health to implement recommendations made by an independent third-party Mediator to treat midwives comparably to other health ...